Skip to content

Category: Science Medical

Ananda Scientific and Benta Sign Memorandum on Advancing Treatments for PTSD

By API User

WILMINGTON, Del. & LYON, France–BUSINESS WIRE– Ananda Scientific Inc., a clinical-stage drug development company advancing innovative therapies for high-impact neuropsychiatric disorders, today announced the signing of a Memorandum of Understanding (MOU) with Benta SAS. The MOU expresses the parties’ intent to explore a potential collaboration focused on accelerating the development and future availability of a … Continued

Australia can eliminate cervical cancer by 2035 with stronger screening and access

By API User

Australia remains on track to eliminate cervical cancer as a public health problem by 2035 if vaccination and screening rates are maintained. But new data shows participation and follow-up delays continue to slow progress, particularly among younger and regional women. According to Cancer Australia’s 2025 update, an estimated 1,030 new cervical cancer cases and 243 deaths were … Continued

AUSTRALIA’S FIRST SOUND MEDICINE STUDIO OPENS IN SYDNEY, AS WELLNESS SPENDING SURGES NATIONWIDE

By API User

Key Facts: Australia’s wellness economy is valued at AUD $196 billion, ranking 10th globally and growing by 10.9% in recent years Australia’s first immersive sound medicine studio, Frequency Lab, has opened in Newtown, Sydney, offering sound therapy sessions based on neuroscience The studio features sonic waterbeds and light meditation systems, combining ancient instruments with modern … Continued

WHEN RELATIONSHIPS END, MEN’S MENTAL HEALTH CAN BE AT SERIOUS RISK – NEW DATA SHOWS CONNECTION IS PROTECTION

By API User

As Australians mark Movember and shine a light on men’s mental health, Relationships Australia NSW is calling for greater awareness of the emotional toll of relationship breakdown on men – and the need for better access to support services. A long-term Australian study of more than 14,000 men found a significant rise in suicidal thoughts … Continued

Blood test offers hope for more effective ovarian cancer treatment

By API User

New clinical research has identified a blood test that can reveal which women are more likely to respond to particular treatment for ovarian cancer, known as PARP inhibitor therapy.  More than 300,000 women are diagnosed with ovarian cancer globally each year, including 1,700 in Australia.   The four-year clinical trial across 15 Australian hospitals – known … Continued

Scientists unearth Australia’s ancient ‘drop crocs’

By API User

Key Facts: The discovery of Australia’s oldest known crocodile eggshells is helping UNSW scientists unlock clues to animals and ecosystems that thrived millions of years ago, before Australia became an island continent. In a local grazier’s backyard in the small southeast QLD town of Murgon, scientists have been digging for decades in what looks like … Continued

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma

By API User

Promega MSI technology will aid in the identification of patients with microsatellite stable (MSS) endometrial carcinoma MADISON, Wis.–BUSINESS WIRE– The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate® MSI Dx Analysis System as a companion diagnostic designed to identify patients with microsatellite stable (MSS; defined as not MSI-high [not MSI-H]) endometrial carcinoma … Continued

Results of Australia’s first injectable opioid treatment trial announced at 2025 APSAD conference

By API User

Media Release                                  11th November 2025   The results of Australia’s first injectable opioid treatment trial were revealed at the 2025 APSAD (The Australasian Professional Society on Alcohol and other Drugs) conference in Sydney today.   Two presentations today outlined the initial findings of the trial – one by Dr Jake Rance, Centre for Social Research … Continued

Samsung Epis Holdings Announces Establishment of Epis NexLab, a New Subsidiary to Advance Next-Generation Biotechnology Platforms

By API User

INCHEON, Korea–BUSINESS WIRE– Samsung Epis Holdings Co., Ltd. today announced the establishment of Epis NexLab Co., Ltd., a new subsidiary that will focus on the development of next-generation biotechnology platforms. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110979915/en/ Peter Seongwon Hong will serve as the Chief Executive Officer (CEO) of Epis NexLab, … Continued